Surveillance and outbreak report Open Access
Like 0


During the 2009/10 influenza A(H1N1)pdm09 pandemic, the five Nordic countries adopted different approaches to pandemic vaccination. We compared pandemic vaccination strategies and severe influenza outcomes, in seasons 2009/10 and 2010/11 in these countries with similar influenza surveillance systems. We calculated the cumulative pandemic vaccination coverage in 2009/10 and cumulative incidence rates of laboratory confirmed A(H1N1)pdm09 infections, intensive care unit (ICU) admissions and deaths in 2009/10 and 2010/11. We estimated incidence risk ratios (IRR) in a Poisson regression model to compare those indicators between Denmark and the other countries. The vaccination coverage was lower in Denmark (6.1%) compared with Finland (48.2%), Iceland (44.1%), Norway (41.3%) and Sweden (60.0%). In 2009/10 Denmark had a similar cumulative incidence of A(H1N1)pdm09 ICU admissions and deaths compared with the other countries. In 2010/11 Denmark had a significantly higher cumulative incidence of A(H1N1)pdm09 ICU admissions (IRR: 2.4; 95% confidence interval (CI): 1.9–3.0) and deaths (IRR: 8.3; 95% CI: 5.1–13.5). Compared with Denmark, the other countries had higher pandemic vaccination coverage and experienced less A(H1N1)pdm09-related severe outcomes in 2010/11. Pandemic vaccination may have had an impact on severe influenza outcomes in the post-pandemic season. Surveillance of severe outcomes may be used to compare the impact of influenza between seasons and support different vaccination strategies.


Article metrics loading...

Loading full text...

Full text loading...



  1. Pandemic influenza A (H1N1) 2009 virus vaccine - conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts. Wkly Epidemiol Rec. 2009;84(49):505-8. PMID: 19960623 
  2. Johansen K, Nicoll A, Ciancio BC, Kramarz P. Pandemic influenza A(H1N1) 2009 vaccines in the European Union. Euro Surveill. 2009;14(41):19361.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19361 PMID: 19883538 
  3. Wichmann O, Stöcker P, Poggensee G, Altmann D, Walter D, Hellenbrand W, et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill. 2010;15(18):19561.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19561 PMID: 20460094 
  4. Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, et al. Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellón, Spain. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine. 2010;28(47):7460-7.  https://doi.org/10.1016/j.vaccine.2010.09.042  PMID: 20875486 
  5. Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med. 2011;8(1):e1000388.  https://doi.org/10.1371/journal.pmed.1000388  PMID: 21379316 
  6. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C. Sebastian Pillai P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill. 2011;16(2):pii=19763. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763
  7. Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med. 2010;363(25):2416-23.  https://doi.org/10.1056/NEJMoa1006736  PMID: 21158658 
  8. Widgren K, Magnusson M, Hagstam P, Widerström M, Örtqvist Å, Einemo IM, et al. Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro Surveill. 2013;18(15):20447.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20447 PMID: 23594578 
  9. Castilla J, Moran J, Martinez-Artola V, Reina G, Martinez-Baz I, Garcia Cenoz M, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveill. 2011;16(7):19799.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19799 PMID: 21345321 
  10. Pebody R, Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill. 2011;16(6):19791.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19791 PMID: 21329644 
  11. Kristiansen IS, Pedersen KM. [Health care systems in the Nordic countries--more similarities than differences?]. Tidsskr Nor Laegeforen. 2000;120(17):2023-9. PMID: 11008540 
  12. Nordic Medico-Statistical Committee 103:2015 (NOMESCO). Health Statistics in the Nordic Countries 2015. Copenhagen: NOMESCO;2015. Available from: http://norden.diva-portal.org/smash/get/diva2:874109/FULLTEXT01.pdf.
  13. Mølbak K, Widgren K, Jensen KS, Ethelberg S, Andersen PH, Christiansen AH, et al. Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark. Vaccine. 2011;29(Suppl 2):B63-9.  https://doi.org/10.1016/j.vaccine.2011.03.064  PMID: 21757107 
  14. Lyytikainen O, Kuusi M, Snellman M, Virtanen M, Eskola J, Ronkko E, et al. Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010. Euro Surveill. 2011;16(27):19908.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19908 PMID: 21794216 
  15. Sigmundsdottir G, Gudnason T, Ólafsson Ö, Baldvinsdóttir GE, Atladottir A, Löve A, et al. Surveillance of influenza in Iceland during the 2009 pandemic. Euro Surveill. 2010;15(49):19742.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19742 PMID: 21163181 
  16. The Swedish Institute for Communicable Disease Control (Smittskyddsinstitutet). The Influenza A(H1N1)2009 Pandemic in Sweden, 2009-2010. 2011. Available from: http://www.folkhalsomyndigheten.se/
  17. Direktoratet for samfunnssikkerhet of beredskap. Rapport Ny influenza A(H1N1)2009. 2010. Available from: http://www.dsb.no/Global/Publikasjoner/2010/Rapporter/PandemiRapport.pdf
  18. Gubbels S, Krause TG, Bragstad K, Perner A, Mølbak K, Glismann S. Burden and characteristics of influenza A and B in Danish intensive care units during the 2009/10 and 2010/11 influenza seasons. Epidemiol Infect. 2013;141(4):767-75.  https://doi.org/10.1017/S0950268812001471  PMID: 22793496 
  19. Guzmán Herrador BR, Aavitsland P, Feiring B, Riise Bergsaker MA, Borgen K. Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. BMC Infect Dis. 2012;12(1):63.  https://doi.org/10.1186/1471-2334-12-63  PMID: 22429643 
  20. Voldstedlund M, Haarh M, Mølbak K, the MiBa Board of Representatives. The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill. 2014;19(1):pii=20667.  https://doi.org/http://dx.doi.org/10.2807/1560-7917.ES2014.19.1.20667 
  21. Statens Serum Institut. Influenza-News - week 18, 2009. April 2009. Available from: http://www.ssi.dk/~/media/Indhold/EN%20-%20engelsk/EPI-NEWS/2009/pdf/EPI-NEWS%20-%202009%20-%20No%2018.ashx
  22. Statens Serum Institut. Influenza-News - week 27, 2009. July 2009. Available from: http://www.ssi.dk/~/media/Indhold/EN%20-%20engelsk/EPI-NEWS/2009/pdf/EPI-NEWS%20-%202009%20-%20No%2027-29.ashx
  23. Aavitsland B, Blystad H, Hauge B, Borgen K, Hungnes F, Feiring B, et al. Folkehelseinstituttet under influensapandemien 2009 – Delrapport: Rådgivning. April 2013. Available from: http://www.fhi.no/eway/default.aspx?pid=239&trg=Content_6503&Main_6157=6246:0:25,5498&MainContent_6246=6503:0:25,5508&Content_6503=6259:106167:25,5508:0:6250:1:::0:0
  24. Danish Society for Infectious Diseases. Guidelines for management of influenza. Dec 2011. Danish. Available from: http://sundhedsstyrelsen.dk/~/media/327B287E85704D6ABE32DA4562CF0AE3.ashx
  25. The Swedish Institute for Communicable Disease Control (Smittskyddsinstitutet). Influenza in Sweden. Season 2010-2011. Feb 2012. Available from: http://www.folkhalsomyndigheten.se/pagefiles/15028/influenza-in-sweden-2010-2011.pdf
  26. O’Flanagan. Cotter S, Mereckiene J. Pandemic A(H1N1) 2009 Influenza Vaccination Survey, Influenza season 2009/2010. Venice II consortium. Available from: http://venice.cineca.org/Final_Report_VENICE_Pandemic_Influenza_2009.pdf
  27. Mølbak K, Widgren K, Jensen KS, Ethelberg S, Andersen PH, Christiansen AH, et al. Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark. Vaccine. 2011;29(Suppl 2):B63-9.  https://doi.org/10.1016/j.vaccine.2011.03.064  PMID: 21757107 
  28. Blasio BF, Iversen BG, Tomba GS. Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing. PLoS One. 2012;7(1):e30018.  https://doi.org/10.1371/journal.pone.0030018  PMID: 22253862 
  29. Health Protection Agency. Surveillance of influenza and other respiratory viruses in the UK; 2011. Available from: http://www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1296687414154
  30. Mytton OT, Rutter PD, Donaldson LJ, Influenza A. Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year. Euro Surveill. 2012;17(14):20139.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20139 PMID: 22516004 
  31. Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study. Lancet Infect Dis. 2012;12(9):696-702.  https://doi.org/10.1016/S1473-3099(12)70133-0  PMID: 22738894 
  32. Athanasiou M, Baka A, Andreopoulou A, Spala G, Karageorgou K, Kostopoulos L, et al. Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011. Euro Surveill. 2011;16(44):20004.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20004 PMID: 22085621 
  33. Health Protection Surveillance Centre. Influenza surveillance in Ireland – weekly update Influenza week 20 2010 (17th to 23rd May 2010). Dublin: Health Protection Surveillance Centre, May 2010. Available from: http://www.hpsc.ie/hpsc/A-Z/Respiratory/Influenza/SeasonalInfluenza/Surveillance/InfluenzaSurveillanceReports/PreviousInfluenzaSeasonsSurveillanceReports/20092010Season/File,4348,en.pdf
  34. Skowronski DM, Janjua NZ, Hottes TS, De Serres G. Mechanism for seasonal vaccine effect on pandemic H1N1 risk remains uncertain. Clin Infect Dis. 2011;52(6):831-2, author reply 832-3.  https://doi.org/10.1093/cid/cir036  PMID: 21367740 
  35. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess. 2010 Dec;14(55):115-92. doi: .
  36. Waddington CS, Walker WT, Oeser C, Reiner A, John T, Wilkins S, et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ. 2010;340(may27 1):c2649.  https://doi.org/10.1136/bmj.c2649  PMID: 20508026 
  37. Vesikari T, Knuf M, Wutzler P, Karvonen A, Kieninger-Baum D, Schmitt HJ, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med. 2011;365(15):1406-16.  https://doi.org/10.1056/NEJMoa1010331  PMID: 21995388 
  38. Syrjänen RK, Jokinen J, Ziegler T, Sundman J, Lahdenkari M, Julkunen I, et al. Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. PLoS One. 2014;9(9):e108538.  https://doi.org/10.1371/journal.pone.0108538  PMID: 25265186 
  39. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al. Canadian SAVOIR Team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med. 2010;7(4):e1000258.  https://doi.org/10.1371/journal.pmed.1000258  PMID: 20386731 
  40. Mereckiene J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber JT, D'Ancona F, Lévy-Bruhl D, Dematte L, Giambi C, Valentiner-Branth P, Stankiewicz I, Appelgren E, O’Flanagan D, the VENICE project gatekeepers group. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill. 2014;19(16):pii=20780.  https://doi.org/http://dx.doi.org/10.2807/1560-7917.ES2014.19.16.20780 
  41. O’Flanagan. Cotter S, Mereckiene J. Seasonal Influenza Vaccination in EU/EEA, influenza season 2010-11 VENICE II Consortium. Available from: http://venice.cineca.org/Final_Seasonal_Influenza_2010-11.pdf

Data & Media loading...

Comment has been disabled for this content
Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error